- Raised $7.6M grant led by European Innovation Council, Dec 2021
- Raised $6M Series B led by Alon MedTech Ventures, Nov 2021
- Raised $2.3M grant led by Jon DeHaan Foundation, Sep 2019
About
Filterlex Medical Ltd. is a cardiovascular medical device startup developing the CAPTIS®, a full-body embolic protection device. The CAPTIS® is designed to reduce the risk of stroke and other complications during catheter-based structural heart procedures, particularly Transcatheter Aortic Valve Replacement (TAVR). The device is securely positioned in the aorta, protecting its surface, while facilitating a seamless TAVR procedure. Its triple-action design provides full-body embolic protection by deflecting, capturing, and removing embolic particles. It uniquely requires no additional arterial access and does not interfere with the procedure workflow. Filterlex Medical targets hospitals, cardiovascular surgeons, and interventional cardiologists. In 2016, Filterlex joined Alon MedTech Ventures incubator, owned by Dr. Shimon Eckhouse.
Funding history · 9 rounds · $20.0M total
Headcount over time
Q&A
- What is Filterlex Medical's primary focus?
- Filterlex Medical is developing the CAPTIS®, a full-body embolic protection device designed to reduce the risk of stroke and other complications during left-heart procedures, particularly Transcatheter Aortic Valve Replacement (TAVR).
- When was Filterlex Medical founded?
- Filterlex Medical was founded in 2015.
- How many employees does Filterlex Medical currently have?
- Filterlex Medical has 7 employees, falling within the 1-10 employee bucket.
- Has Filterlex Medical announced any positive clinical study results recently?
- In May 2022, Filterlex Medical announced positive results from a first-in-human study for its CAPTIS® Full-Body Embolic Protection Device.
- What was Filterlex Medical's Series A1 investment amount and when was it closed?
- Filterlex Medical closed a $6,000,000 Series A1 investment in November 2021.
- Which program backed Filterlex Medical's embolic protection device in 2019?
- In July 2019, the European Commission Horizon 2020 Program and Jon DeHaan Foundation backed Filterlex Medical's embolic protection device with a grant of $200,000.
- Who are the founders of Filterlex Medical?
- The founders of Filterlex Medical are Sigal Eli (Inventor, Founder & CEO), Eyal Teichman (Founder & CTO), and Giora Weisz (Founder & Chairman of Advisory Board).
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | filterlex.com |
|---|---|
| linkedin.com/company/10372339 | |
| YouTube | youtube.com/channel/UCnosm4BCi4BsyNSMWX2JqCw |
Identifiers & details
| Legal name | Filterlex Medical Ltd. |
|---|---|
| Founded | 2015 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | filterlex.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515276764 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-06-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 1 — shares_capital (1) |
| Registered address | חלמיש 9 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-16 | העברת מניות |